Skip to main content
Top

Drugs

Issue 15/2015

Content (12 Articles)

Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future Prospects

  • Current Opinion

Ilias Giarenis, Dudley Robinson, Linda Cardozo

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia

  • Open Access
  • Therapy in Practice

Matthew K. Ito, Gerald F. Watts

Management of Hematologic Malignancies: Special Considerations in Pregnant Women

  • Therapy in Practice

Odelia Amit, Merav Barzilai, Irit Avivi

Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2

  • Review Article

Nele Boeckx, Marc Peeters, Guy Van Camp, Patrick Pauwels, Ken Op de Beeck, Vanessa Deschoolmeester

Ruxolitinib: A Review in Polycythaemia Vera

  • Adis Drug Evaluation

Kate McKeage

Saxagliptin: A Review in Type 2 Diabetes

  • Adis Drug Evaluation

Sohita Dhillon

Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease

  • Adis Drug Evaluation

Hannah A. Blair, Gillian M. Keating

Flibanserin: First Global Approval

  • AdisInsight Report

Emma D. Deeks

Cobimetinib: First Global Approval

  • AdisInsight Report

Karly P. Garnock-Jones

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images